Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2013 Nov 14;369(20):1968.
doi: 10.1056/NEJMc1311498.

Survival in the prostate cancer prevention trial

Comment

Survival in the prostate cancer prevention trial

Catherine M Tangen et al. N Engl J Med. .
No abstract available

PubMed Disclaimer

Comment on

References

    1. Thompson IM, Jr, Goodman PJ, Tangen CM, et al. Long-term survival of participants in the Prostate Cancer Prevention Trial. N Engl J Med. 2013;369:603–10. - PMC - PubMed
    1. Redman MW, Tangen CM, Goodman PJ, Lucia MS, Coltman CA, Jr, Thompson IM. Finasteride does not increase the risk of high-grade prostate cancer: a bias-adjusted modeling approach. Cancer Prev Res (Phila) 2008;1:174–81. - PMC - PubMed
    1. Summary Minutes of the Oncologic Drugs Advisory Committee Meeting December 1, 2010. ( http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMateria...)
    1. Theoret MR, Ning Y-M, Zhang JJ, Justice R, Keegan P, Pazdur R. The risks and benefits of 5α-reductase inhibitors for prostate-cancer prevention. N Engl J Med. 2011;365:97–9. - PubMed
    1. Pinsky PF, Black A, Grubb R, et al. Projecting prostate cancer mortality in the PCPT and REDUCE chemoprevention trials. Cancer. 2013;119:593–601. - PMC - PubMed

MeSH terms